The independent platform for news, articles and advice for professionals in laboratory medicine

Rapid point-of-care cardiac troponin testing

Chest pain patients presenting at the emergency department are set to benefit from a major development by Royal Philips with the recent announcement that the company has CE marked its cardiac troponin I (cTnI) blood test on the Minicare I‐20 handheld device. Minicare cTnI delivers laboratory-comparable test results in less than 10 minutes near the patient, reducing the time needed to decide on treatment.

Only a single drop of blood is needed, and the result is delivered while the patient is being assessed and a medical history taken. This simplifies the patient‐doctor interaction, helping clinicians provide the best possible care for their patients.

Current guidelines for the diagnosis of myocardial infarction require blood test results of the biomarker cardiac troponin for the 90% of patients who present at A&E with chest pain but are not diagnosed by an ECG. “Blood samples are usually analysed in the hospital laboratory, which can easily take more than an hour to get the result back to the A&E clinician. Point-of-care testing can help to reduce the turnaround time significantly,” said Dr Paul Collinson (St George’s University Hospitals NHS

Foundation Trust).

For high‐risk cardiac patients, such as those with acute coronary syndrome, fast triage and rapid initiation of treatment are critical in order to improve patient outcomes and save lives. Only 10% of chest pain patients can be diagnosed by an ECG, the rest need to rely on additional cardiac marker testing for the diagnosis of myocardial infarction. Clinicians often have to wait up to six hours before it can be decided if they can discharged the patients safely, or if they need to admit them for further tests. Use of the Minicare cTnI supports a reduction of the diagnostic protocol by up to three hours..

www.philips.com

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

British Society for Microbial Technology Annual Microbiology Conference

UK Health Security Agency, Colindale, London
2 May 2024

EQA Reports: Interpreting Key Information & Troubleshooting Tips

ONLINE - Zoom
Thursday 16th May 2024

Participants’ Meeting: UK NEQAS Immunology, Immunochemistry & Allergy

Sheffield Hallam University, City Campus, Howard Street, Sheffield
24th May 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025